COVID Vaccine Boosters: US Exploring Ways To Get Immunocompromised People An Extra Dose

Dosing is capped under emergency use authorizations, but studies show reduced antibody response following primary vaccination series in individuals with compromised immune systems; although BLA approval could allow for off-label prescribing, government officials are exploring other regulatory options for earlier access, including through a study.

Running away
ACIP members fear the growing issue of immunocompromised individuals pursuing an extra COVID-19 vaccine dose is 'running away from us.' • Source: Alamy

US public health officials are looking at regulatory pathways beyond just emergency use authorization amendments to try to give immunocompromised individuals access to additional COVID-19 vaccine doses.

Full approval of a biologics license application could allow for off-labeling prescribing of additional vaccine doses in immunocompromised individuals who...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA Performance Tracker

More from Regulatory Trackers